Navigation Links
Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From Glucose
Date:10/6/2010

Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From... -- EVRY, France, October 6, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Alternative Energies, Gas, Oil & Energy, Green Technology, Biotechnology, Chemical, New Products & Services Click to view news release full screen  

Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From Glucose

 

EVRY, France, October 6, 2010 /PRNewswire/ -- Global Bioenergies, located on the Genopole campus at Evry (France), announces the first prototype of its manufacturing process for the biological production of isobutene. It relies on the use of a bacterial strain harboring an artificial metabolic pathway created by the company.

Global Bioenergies announces that it has reached a key milestone in the development of its process for the transformation of renewable resources into gaseous isobutene (also called isobutylene or methylpropene). An initial series of bacterial strains were developed that can produce isobutene by transforming glucose.

Marc Delcourt, co-founder and CEO of the company, states, "We have achieved our goal to bioproduce isobutene in vivo ahead of target. We are now concentrating our efforts on increasing both the rate and scale of fermentation. We plan to carry out pilot plant tests prior to the industrial exploitation of the process. This phase will require new financial investment."

Philippe Marliere, co-founder and designer of the process, adds, "We have taught a bacterium to convert glucose to isobutene through an entirely novel process. The metabolic layout that we established passes by 3-hydroxy-isovalerate (also called 3-hydroxy-3-methylbutyrate). This chemical intermediate, which is absent from natural bacteria is, in turn, enzymatically converted into isobutene in our strains. The process is set up in accordance with the patent application filed in July 2008."

Jean-Marc Paris, professor at the EcoleSuperieure de Physique et de Chimie (Paris Tech) and a member of the Scientific Advisory Board, concludes, "This is the first time that an artificial metabolic pathway, which leads the production of a light olefin from renewable resources, has been designed and assembled in a micro-organism. These results set a precedent for the in-depth changes which the worldwide chemical industry will have to undergo in the 21st century."

Fuels, as well as a variety of polymers, representing a global market of $29b, can be manufactured from isobutene. Global Bioenergies is now focused on repeating this success with other molecules of the light olefin family, such as ethylene and propylene, each one associated with markets greater than $100b.

http://www.global-bioenergies.com

Press and public relations:

Benedicte.Robert@global-bioenergies.com - Phone: +33-1-64-98-20-50


'/>"/>
SOURCE Global Bioenergies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ground Zero Pharmaceuticals Announces Expansion of Global Consulting in Somatic Cell Therapies
2. Reportlinker Adds Global Synthetic Biology Industry
3. Reportlinker Adds Global Soft Tissue Allografts Industry
4. Reportlinker Adds Cancer Profiling and Pathways: Technologies and Global Markets
5. BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
6. Diagenode Releases Two New Epigenetic Monoclonal 5-hmC Antibodies for Quantifying Global Hydroxymethylation
7. Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview
8. Medix Uses Globalpark to Glean Insights From Over 20,000 Opinion Leaders
9. Chiasma to Present at the UBS Global Life Sciences Conference
10. Seahorse Bioscience to Present at 2010 UBS Global Life Sciences Conference
11. Keryx Biopharmaceuticals to Present at the UBS 2010 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)...   Pulmatrix, Inc . (NASDAQ: PULM ... therapies to address serious pulmonary diseases, today announced that ... lungs of CF patients, PUR1900, has been designated as ... Food & Drug Administration. Under the ... development of novel drugs against important pathogens, Pulmatrix will ...
(Date:1/17/2017)...  Only nine percent of U.S. consumers believe pharmaceutical ... 16 percent believe health insurance companies do, according to ... of U.S. adults believe health care providers (such as ... hospitals (23%). "We are in the midst ... , vice president of reputation management and public affairs ...
(Date:1/17/2017)... ... , ... Pono Ola , a mind-body wellness firm on a mission ... launch of its much-anticipated Pono Board: a re-invented fitness and anti-fatigue balance board that ... a year, the patented Pono Board is the world’s only exercise balance board built ...
(Date:1/17/2017)... ... January 17, 2017 , ... Diagenode, a ... announced a collaboration with the Heidelberg University Hospital and the German Cancer Research ... following the company’s successful launch of its CATS (Capture and Amplification by ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016 Advancements ... experience, health wellness and wellbeing (HWW), and ... in three new passenger vehicles begin to ... gesture recognition, heart beat monitoring, brain wave ... facial monitoring, and pulse detection. These will ...
(Date:12/12/2016)... -- Researchers at Trinity College, Dublin, are opening up ... material with Silly Putty. The mixture (known as "G-putty") ... sense pulse, blood pressure, respiration, and even the ... The research team,s findings were published Thursday in ... Due ...
(Date:12/7/2016)... According to a new market research report "Emotion Detection ... Voice Recognition), Service, Application Area, End User, And Region - Global Forecast to ... 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a Compound ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):